The study focused on assessing oral nalbuphine extended release for cough relief in idiopathic pulmonary fibrosis patients. A randomized, double-blind, placebo-controlled trial design was employed ...
In the year 2024, the Cold & Cough Remedies market market in G7 countries generated a revenue of US$17.17bn. It is projected to have an annual growth rate of 4.65% (CAGR 2024-2029). Among the G7 ...
In 2024, the revenue generated in the Cold & Cough Remedies market market in the country in Eurasian Economic Union (EAEU) amounts to US$1.33bn. It is projected that the market will experience an ...